vaccines
Respiratory syncytial virus and the race for a vaccine
November 21 by Leila HawkinsAs cases of RSV surge vaccine manufacturers are racing to find a treatment
Bivalent Covid-19 vaccines: What they are and what they do
November 01 by Leila HawkinsAs bivalent Covid-19 vaccines are rolled out, we look at how effective they are
Uganda declares lockdown, Merck to donate vaccine to tackle Ebola
October 26 by Leila HawkinsUganda is trying to contain the latest outbreak of the Sudan variant of Ebola
Top 10 vaccine manufacturers worldwide
October 21 by Leila HawkinsPharma IQ lists the 10 biggest vaccine manufacturers in the world
Tackling infectious disease with innovative R&D approaches
October 04 by Patrice HugoThis guest blog explores the lessons learned from Covid-19 to develop new vaccines for infectious diseases
A guide to manufacturing biologics
July 07 by Leila HawkinsPharma IQ explores the complexities of manufacturing biologics
New Covid-19 vaccines show high immunity against Omicron
June 27 by Leila HawkinsPharma companies release successful results for vaccines targeting Omicron
Keeping tabs on Covid-19: A mixed picture around the world
January 25 by Leila HawkinsOmicron peaks in some parts of Europe, but WHO warns this is not the end. Meanwhile Merck approves generic anti-viral for poorer nations
Keeping tabs on pharma: Push for Africa to localize its pharmaceutical development
July 02 by Emily UwemedimoDiscover how big pharma companies plan to support African nations via the continent’s first mRNA vaccine manufacturing hub
Philippines FDA to speed up Covid-19 clinical trial approval decisions by 50 per cent
February 18 by Emily UwemedimoJanssen among pharma firms being provided increased transparency of regulatory decisions on clinical trial processes in the Philippines
Enable biologics therapeutic development with high-density cell banking
February 17 by Pharma IQDiscover solutions to increase the density in cell cultures while preserving cell viability
Keeping tabs on Covid-19: Sustainable facemask that repel viral bacteria designed, test to neutralize Covid-19 antibodies begin and big pharma partnership aims to accelerate vaccine production
June 26 by Emily UwemedimoPharma IQ looks at how pharmaceutical manufacturers are ramping up production in an attempt to find a cure for coronavirus